Completed NA NCT00002197

A Study of 1592U89 in HIV-Infected Children

1592U89 Open-Label Protocol for Pediatric Patients With HIV Infection.

Sponsor: Glaxo Wellcome

Updated 5 times since 2017 Last updated: Jun 23, 2005

A NA clinical study on HIV Infections, this trial is completed. The trial is conducted by Glaxo Wellcome and has accumulated 5 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Glaxo Wellcome

Data source: NIH AIDS Clinical Trials Information Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Research Triangle Park, United States

Related Trials

By Sponsor 10

Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
Shared: Glaxo Wellcome

Completed
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
Shared: Glaxo Wellcome

Completed
A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
Shared: Glaxo Wellcome

Completed
A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease
Shared: Glaxo Wellcome

Completed
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
Shared: Glaxo Wellcome

Completed
A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease
Shared: Glaxo Wellcome

Completed
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Shared: Glaxo Wellcome

Completed
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
Shared: Glaxo Wellcome

Completed
A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
Shared: Glaxo Wellcome

Completed
A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children
Shared: Glaxo Wellcome

Completed

By Intervention 10

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
Shared: Abacavir sulfate

Completed
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
Shared: Abacavir sulfate

Completed
A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
Shared: Abacavir sulfate

Completed
Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320
Shared: Abacavir sulfate

Completed
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
Shared: Abacavir sulfate

Completed
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
Shared: Abacavir sulfate

Completed
A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
Shared: Abacavir sulfate

Completed
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
Shared: Abacavir sulfate

Completed
The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children
Shared: Abacavir sulfate

Completed
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
Shared: Abacavir sulfate

Completed

By Location 10

A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
Shared: Research Triangle Park, United States

Completed
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
Shared: Research Triangle Park, United States

Completed
A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases
Shared: Research Triangle Park, United States

Completed
A Prospective Double-Blind Study of Retrovir in Early HIV Infection
Shared: Research Triangle Park, United States

Completed
A Study of 1592U89 in HIV-Infected Adults
Shared: Research Triangle Park, United States

Completed
A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease
Shared: Research Triangle Park, United States

Completed
A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
Shared: Research Triangle Park, United States

Completed
An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine
Shared: Research Triangle Park, United States

Completed
An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2
Shared: Research Triangle Park, United States

Completed
A Study of Nonoxynol-9 (N-9) and HIV Infection
Shared: Research Triangle Park, United States

Completed